InvaTech Pharma Solutions

InvaTech Pharma Solutions is a specialty generic pharmaceutical developer and manufacturer based in East Brunswick, New Jersey. Founded in 2013, the company specializes in producing prescription generic products across a wide range of therapeutic areas, including cardiovascular, gastrointestinal, dermatological, respiratory, and ophthalmic treatments. InvaTech operates a 46,000-square-foot FDA-compliant facility equipped for oral solid, liquid oral, and injectable dosage forms. The company utilizes cost- and profit-sharing partnerships with established U.S. distributors to market its portfolio of approved Abbreviated New Drug Applications (ANDAs). In February 2025, InvaTech filed for Chapter 11 bankruptcy protection to address liquidity constraints and restructure its operations.